Complete dosage information for 5F-PB-22 — threshold, light, common, strong, and heavy dose ranges across 2 routes of administration.
Full 5F-PB-22 profileImportant Safety Notice
Dosage information is for harm reduction purposes only. Individual sensitivity varies greatly. Always start with the lowest effective dose and work your way up slowly. Never eyeball doses — use a milligram scale.
overdose will cause physical discomfort including heart palpitations, vertigo and sedation at much lower than dangerous doses, usually causing the user to suffer large amounts of anxiety or to fall asleep. There have been many hospital reports involving 5F-PB-22, as well as cases of post-mortem analysis involving 5F-PB-22. Five deaths have been associated with the use of 5F-PB-22 in the United States., particularly in vulnerable individuals with risk factors for psychotic illnesses (like a past or family history of schizophrenia). - **Germany:** 5F-PB-22 is controlled under Anlage II BtMG (*Narcotics Act, Schedule II*) as of December 13, 2014. It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license. - **Latvia:** 5F-PB-22 is a Schedule I controlled substance. - **Switzerland:** 5F-PB-22 is a controlled substance specifically named under Verzeichnis D. - **United Kingdom:** 5F-PB-22 is a Class B controlled substance under the third-generation synthetic cannabinoids generic definition, which came into effect on December 14, 2016 and is illegal to possess, produce, supply, or import. - **United States:** In January 2014, 5F-PB-22 was designated as a Schedule I controlled substance in the United States. - Responsible use - JWH-018 - THJ-018 - 5F-AKB48 - Synthetic cannabinoid - Cannabis - 5F-PB-22 (Wikipedia) - 5F-PB-22 (Isomer Design)
A common oral dose of 5F-PB-22 is 3–5 mg.
The threshold dose for 5F-PB-22 via oral is approximately 1 mg.
5F-PB-22 typically lasts 2–3 hours via oral.
5F-PB-22 can be taken via oral, smoked. Each route has different dosage ranges and onset times.